A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma. [electronic resource]
Producer: 20120321Description: 157-65 p. digitalISSN:- 1573-4978
- Animals
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Camptothecin -- analogs & derivatives
- Carboxylesterase -- metabolism
- Cell Transplantation -- methods
- DNA Primers -- genetics
- Drug Carriers -- metabolism
- Drug Evaluation, Preclinical
- Female
- Genes, Transgenic, Suicide -- genetics
- Irinotecan
- Lung Neoplasms -- drug therapy
- Magnetics
- Melanoma -- drug therapy
- Mice
- Mice, Inbred C57BL
- Monocyte-Macrophage Precursor Cells -- metabolism
- Nanoparticles
- Prodrugs -- administration & dosage
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.